Related Experiment Videos
Persistent disease after surgery for primary hyperparathyroidism: the long-term outcome
1Department of Surgery, Sahlgrenska University Hospital, Göteborg, Sweden. g,hedback@home.se
European Journal of Endocrinology
|January 10, 2004
Summary
Persistent primary hyperparathyroidism significantly impacts patient health long-term. Surgical treatment is supported, as cured patients report better health outcomes than those with persistent disease.
Area of Science:
- Endocrinology
- Surgical Oncology
Background:
- Primary hyperparathyroidism (PHPT) is a common endocrine disorder.
- Long-term outcomes and health status after PHPT treatment require further investigation.
Purpose of the Study:
- To evaluate the long-term clinical and laboratory status of patients with persistent primary hyperparathyroidism after treatment cessation.
- To assess the risks associated with persistent disease and the need for extensive surgery.
Main Methods:
- Retrospective analysis of 896 patients operated on for PHPT, with a mean follow-up of 10.3 years.
- Data collection via questionnaire on health status, medication, and diagnoses.
- Comparison of 13 patients with persistent disease to 509 surgically cured patients.
Main Results:
- Serum calcium and creatinine levels remained largely stable, with five patients showing normal calcium at follow-up.
- All 19 investigated patients were considered hyperparathyroid, exhibiting significant cardiovascular morbidity.
- Persistent disease occurred in 5.5% after one operation and 2.1% after reoperation; extensive surgery was needed in 2%.
Conclusions:
- Patients with cured PHPT reported significantly better health than those with persistent disease.
- Serious deterioration of laboratory values was uncommon in persistent cases.
- Surgical treatment remains the recommended approach for primary hyperparathyroidism.